BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 12453974)

  • 1. Deficit of somatostatin-like immunoreactivity in the vitreous fluid of diabetic patients: possible role in the development of proliferative diabetic retinopathy.
    Simó R; Lecube A; Sararols L; García-Arumí J; Segura RM; Casamitjana R; Hernández C
    Diabetes Care; 2002 Dec; 25(12):2282-6. PubMed ID: 12453974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Somatostatin molecular variants in the vitreous fluid: a comparative study between diabetic patients with proliferative diabetic retinopathy and nondiabetic control subjects.
    Hernández C; Carrasco E; Casamitjana R; Deulofeu R; García-Arumí J; Simó R
    Diabetes Care; 2005 Aug; 28(8):1941-7. PubMed ID: 16043736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitreous levels of vascular cell adhesion molecule and vascular endothelial growth factor in patients with proliferative diabetic retinopathy: a case-control study.
    Hernández C; Burgos R; Cantón A; García-Arumí J; Segura RM; Simó R
    Diabetes Care; 2001 Mar; 24(3):516-21. PubMed ID: 11289478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Free insulin growth factor-I and vascular endothelial growth factor in the vitreous fluid of patients with proliferative diabetic retinopathy.
    Simó R; Lecube A; Segura RM; García Arumí J; Hernández C
    Am J Ophthalmol; 2002 Sep; 134(3):376-82. PubMed ID: 12208249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravitreous levels of hepatocyte growth factor/scatter factor and vascular cell adhesion molecule-1 in the vitreous fluid of diabetic patients with proliferative retinopathy.
    Hernández C; Carrasco E; García-Arumí J; Maria Segura R; Simó R
    Diabetes Metab; 2004 Sep; 30(4):341-6. PubMed ID: 15525877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravitreous vascular endothelial growth factor and hypoxia-inducible factor 1a in patients with proliferative diabetic retinopathy.
    Wang X; Wang G; Wang Y
    Am J Ophthalmol; 2009 Dec; 148(6):883-9. PubMed ID: 19837381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitreous levels of vascular endothelial growth factor are not influenced by its serum concentrations in diabetic retinopathy.
    Burgos R; Simó R; Audí L; Mateo C; Mesa J; García-Ramírez M; Carrascosa A
    Diabetologia; 1997 Sep; 40(9):1107-9. PubMed ID: 9300249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravitreous hepatocyte growth factor in patients with proliferative diabetic retinopathy: a case-control study.
    Simó R; Vidal MT; García-Arumí J; Carrasco E; García-Ramírez M; Segura RM; Hernández C
    Diabetes Res Clin Pract; 2006 Jan; 71(1):36-44. PubMed ID: 16029908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-8, monocyte chemoattractant protein-1 and IL-10 in the vitreous fluid of patients with proliferative diabetic retinopathy.
    Hernández C; Segura RM; Fonollosa A; Carrasco E; Francisco G; Simó R
    Diabet Med; 2005 Jun; 22(6):719-22. PubMed ID: 15910622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipopolysaccharide-binding protein and soluble CD14 in the vitreous fluid of patients with proliferative diabetic retinopathy.
    Hernández C; Ortega F; García-Ramírez M; Villarroel M; Casado J; García-Pascual L; Fernández-Real JM; Simó R
    Retina; 2010 Feb; 30(2):345-52. PubMed ID: 20175275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CORRELATION OF INCREASED INTRAVITREOUS WNT3A WITH VASCULAR ENDOTHELIAL GROWTH FACTOR IN PROLIFERATIVE DIABETIC RETINOPATHY.
    Gao X; Ma K; Lu N; Hong T; Xu Y; Peng X
    Retina; 2016 Apr; 36(4):812-8. PubMed ID: 26418446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatocyte growth factor in vitreous fluid of patients with proliferative diabetic retinopathy and other retinal disorders.
    Katsura Y; Okano T; Noritake M; Kosano H; Nishigori H; Kado S; Matsuoka T
    Diabetes Care; 1998 Oct; 21(10):1759-63. PubMed ID: 9773744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atrial natriuretic peptide in the vitreous humor and epiretinal membranes of patients with proliferative diabetic retinopathy.
    Rollin R; Mediero A; Martínez-Montero JC; Roldán-Pallarés M; Suárez-Leoz M; Vidal-Fernández P; Cortés-Valdés C; Fernández-Cruz A; Fernández-Durango R
    Mol Vis; 2004 Jul; 10():450-7. PubMed ID: 15273657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated protein carbonyl and HIF-1α levels in eyes with proliferative diabetic retinopathy.
    Loukovaara S; Koivunen P; Inglés M; Escobar J; Vento M; Andersson S
    Acta Ophthalmol; 2014 Jun; 92(4):323-7. PubMed ID: 23718695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deficit of somatostatin in the vitreous fluid of patients with diabetic macular edema.
    Simó R; Carrasco E; Fonollosa A; García-Arumí J; Casamitjana R; Hernández C
    Diabetes Care; 2007 Mar; 30(3):725-7. PubMed ID: 17327350
    [No Abstract]   [Full Text] [Related]  

  • 16. Accumulation of NH2-terminal fragment of connective tissue growth factor in the vitreous of patients with proliferative diabetic retinopathy.
    Hinton DR; Spee C; He S; Weitz S; Usinger W; LaBree L; Oliver N; Lim JI
    Diabetes Care; 2004 Mar; 27(3):758-64. PubMed ID: 14988298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitreous levels of angiopoietin 2 and vascular endothelial growth factor in patients with proliferative diabetic retinopathy.
    Watanabe D; Suzuma K; Suzuma I; Ohashi H; Ojima T; Kurimoto M; Murakami T; Kimura T; Takagi H
    Am J Ophthalmol; 2005 Mar; 139(3):476-81. PubMed ID: 15767056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated gamma-aminobutyric acid, glutamate, and vascular endothelial growth factor levels in the vitreous of patients with proliferative diabetic retinopathy.
    Ambati J; Chalam KV; Chawla DK; D'Angio CT; Guillet EG; Rose SJ; Vanderlinde RE; Ambati BK
    Arch Ophthalmol; 1997 Sep; 115(9):1161-6. PubMed ID: 9298058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erythropoietin is expressed in the human retina and it is highly elevated in the vitreous fluid of patients with diabetic macular edema.
    Hernández C; Fonollosa A; García-Ramírez M; Higuera M; Catalán R; Miralles A; García-Arumí J; Simó R
    Diabetes Care; 2006 Sep; 29(9):2028-33. PubMed ID: 16936148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nitric oxide and vascular endothelial growth factor concentrations are increased but not related in vitreous fluid of patients with proliferative diabetic retinopathy.
    Hernández C; Lecube A; Segura RM; Sararols L; Simó R
    Diabet Med; 2002 Aug; 19(8):655-60. PubMed ID: 12147146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.